MONOGENIC IBD: DIAGNOSTIC AND THERAPEUTIC CHALLENGES
DOI:
https://doi.org/10.52340/jecm.2025.02.19Keywords:
monogenic IBD, diagnosis, therapy, challengesAbstract
Early-onset inflammatory bowel disease (EO-IBD), especially when presenting before 6 months of age, raises a high index of suspicion for monogenic IBD. These rare, genetically driven disorders are associated with atypical presentations, including extraintestinal manifestations such as arthritis. Differentiating them from more common allergic or infectious conditions poses significant diagnostic and therapeutic challenges. We present a case of an infant with persistent hematochezia and recurrent arthritis, ultimately guiding immunologic and genetic investigation for monogenic IBD.
Downloads
References
Uhlig HH, Schwerd T, et al. The Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease. Gastroenterology. 2014;147(5):990–1007.e3. doi:10.1053/j.gastro.2014.07.023
Kelsen JR, Sullivan KE. Inflammatory Bowel Disease in Primary Immunodeficiencies. Curr Allergy Asthma Rep. 2017;17(8):57. doi:10.1007/s11882-017-0720-3
Ouahed J, Spencer E, Kotlarz D, et al. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. Inflamm Bowel Dis. 2020;26(6):820–842. doi:10.1093/ibd/izz284
Snapper SB. Advances in understanding the pathogenesis of IBD: genes and environment. Gastroenterology. 2021;160(6):1886–1899.
Uhlig HH. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut. 2013;62(12):1795–1805.
Kelsen JR, Baldassano RN. Inflammatory Bowel Disease: The Difference Between Children and Adults. Inflamm Bowel Dis. 2008;14(Suppl 2):S9–S11.
Sormani MP, De Rossi N, Schiavetti I, et al. Disease-Modifying Therapies and COVID-19 Severity in Multiple Sclerosis. Ann Neurol. 2021;89(4):780–789.